[1]
Alvarez Crespo, A.R. et al. 2015. Characterization of adverse events during the treatment with heberprot-p® in four cuban provinces. Horizonte Sanitario. 14, 2 (Sep. 2015), 42–46. DOI:https://doi.org/10.19136/hs.a14n2.950.